Eric Crombez

1.1k citations

30 papers · 856 indexed · h-index 17

Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders 9
Physiology top 5%
- Lysosomal Storage Disorders Research 13
Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 3
Cell Biology top 10%
- Cellular transport and secretion 3
Rheumatology top 10%
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 6
Molecular Biology
- Biochemical and Molecular Research 4
- Mitochondrial Function and Pathology 3
Biotechnology
- Transgenic Plants and Applications 3

Co-authors: Stephen D. Cederbaum Ari Zimran Nicola Longo Deborah Elstein Barbara K. Burton Heidi Christ‐Schmidt Jon A. Wolff Alex Dorenbaum
Cited by: Clinical Biochemistry Physiology Biochemistry
Journals: Molecular Genetics and Metabolism (11 papers)American Journal of Hematology (6 papers)The Journal of Pediatrics (3 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Eric Crombez

28 papers receiving 837 citations

Peers

Countries citing papers authored by Eric Crombez

Since Specialization

Citations

This map shows the geographic impact of Eric Crombez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Crombez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Crombez more than expected).

Fields of papers citing papers by Eric Crombez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Crombez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Crombez. The network helps show where Eric Crombez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eric Crombez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Crombez Line = papers co-authored together Eric Crombez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P171: Durable efficacy and safety of DTX301: Long-term follow up of a phase 1/2 trial in adults with ornithine transcarbamylase deficiency* Genetics in Medicine Open ·Cary O. Harding,Janet Thomas,J. Chin,María L. Couce,Tarekegn Geberhiwot,Nathalie Guffon,Jakub Zajaczkowski,Aneal Khan,Laura Konczal,Maureen Peters,Alex Epstein,J. Lawrence Merritt,Eric Crombez	2025	2
2	Safety and Efficacy of DTX401 , an AAV8 ‐Mediated Liver‐Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a ( GSDIa ) Journal of Inherited Metabolic Disease ·David A. Weinstein,Terry G. J. Derks,David Rodriguez‐Buritica,Ayesha Ahmad,María L. Couce,John J. Mitchell,正嗣中川,Shigeo Horie,北野誠,Stimmlage -Das Minetti Quartett Im Gespräch,Melanie M. van der Klauw,Foekje de Boer,He Xiuhui,Atri Bandyopadhyay,Miguel Ángel Martínez Olmos,Asma Kausar,Abdolkarim Hosseini,Gabriel Fernando Duarte de Bairros,Eric Crombez	2025	7
3	Long-term safety and efficacy of DTX301 in adults with late-onset ornithine transcarbamylase (OTC) deficiency: A Phase 1/2 trial Molecular Genetics and Metabolism ·Janet Thomas,Wen‐Hann Tan,Aneal Khan,Laura Konczal,J. Chin,Jakub Zajaczkowski,Chris Cassella,Tarekegn Geberhiwot,Nathalie Guffon,Cary O. Harding,Kaushik Patra,J. Lawrence Merritt,Eric Crombez	2024	1
4	COHORT 1-4 RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF AN AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA) Molecular Genetics and Metabolism ·David Rodriguez‐Buritica,Ayesha Ahmad,Jack Lehrecke,Terry G. J. Derks,John J. Mitchell,正嗣中川,David A. Weinstein,Connie Lee,Vassili Valayannopoulos,Eric Crombez	2022	0
5	101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX) Blood ·Steven W. Pipe,Kimo C. Stine,Anita Rajasekhar,Tamara Everington,Allen Poma,Eric Crombez,А И Митрофанова	2017	23
6	Metachromatic Leukodystrophy Journal of Child Neurology ·Florian Eichler,Timothy M. Cox,Eric Crombez,Christine í Dali,Alfried Kohlschütter	2016	26
7	Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase Molecular Genetics and Metabolism ·Laurie D. Smith,William J. Rhead,Joel Charrow,Suma P. Shankar,Ashish Bavdekar,Nicola Longo,Rebecca Mardach,Paul Harmatz,Thomas N. Hangartner,Hak‐Myung Lee,Eric Crombez,Gregory M. Pastores	2015	26
8	Safety and efficacy of long-term enzyme replacement therapy with velaglucerase alfa in patients with type 1 Gaucher disease transitioned from imiglucerase Molecular Genetics and Metabolism ·Deborah Elstein,Pilar Giraldo,Atul Mehta,Gregory M. Pastores,William J. Rhead,Laurie D. Smith,Nan Wang,Eric Crombez,Ari Zimran	2014	0
9	Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study American Journal of Hematology ·Derlis Gonzalez,Hadhami Ben Turkia,Elena Lukina,Isaac Kisinovsky,Do‘smuradova Yulduz,Deborah Elstein,David M. Zahrieh,Eric Crombez,Kiran Bhirangi,Norman W. Barton,Ari Zimran	2012	62
10	Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease American Journal of Hematology ·Hadhami Ben Turkia,Derlis Gonzalez,Norman W. Barton,Ari Zimran,Madhulika Kabra,Elena Lukina,Pilar Giraldo,Isaac Kisinovsky,Ashish Bavdekar,Do‘smuradova Yulduz,Neerja Gupta,Priya S. Kishnani,Roland S. Manalang,Nan Wang,Eric Crombez,Kiran Bhirangi,Atul Mehta	2012	48
11	Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study The Journal of Pediatrics ·Friedrich K. Trefz,Barbara K. Burton,Nicola Longo,谷雅志,Daniel Gruskin,Alex Dorenbaum,Emil Kakkis,Eric Crombez,Dorothy K. Grange,Paul Harmatz,Mark Lipson,Andrzej Milanowski,Linda M. Randolph,Jerry Vockley,Chester B. Whitley,Jon A. Wolff,Judith D. Bebchuk,Heidi Christ‐Schmidt,Julia B. Hennermann	2009	156
12	Maternal glutaric acidemia, type I identified by newborn screening Molecular Genetics and Metabolism ·Eric Crombez,Stephen D. Cederbaum,Elaine Spector,KuoHsiung Lee,Denise Salazar,Julie Neidich,Stephen I. Goodman	2008	30
13	Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria American Journal of Medical Genetics Part A ·Phillip Lee,Eileen P. Treacy,Eric Crombez,Melissa Wasserstein,Lewis Waber,Jon A. Wolff,U. Wendel,Alex Dorenbaum,Judith D. Bebchuk,Heidi Christ‐Schmidt,Margretta R. Seashore,Marcello Giovannini,Barbara K. Burton,Andrew A. M. Morris	2008	79
14	Clinical and Molecular Heterogeneity in Patients with the CblD Inborn Error of Cobalamin Metabolism The Journal of Pediatrics ·Isabelle R. Miousse,David Watkins,David Coelho,Tony Rupar,Eric Crombez,Éric Vilain,Jonathan A. Bernstein,Tina M. Cowan,Christopher Lee‐Messer,Gregory M. Enns,Brian Fowler,David S. Rosenblatt	2008	34
15	Expanded newborn screening identifies maternal primary carnitine deficiency Molecular Genetics and Metabolism ·Lisa A. Schimmenti,Eric Crombez,Bernd Schwahn,Bryce A. Heese,Timothy C. Wood,Richard J. Schroer,Walter Ojakäär,Stephen Cederbaum,Kyriakie Sarafoglou,Mark McCann,Piero Rinaldo,Dietrich Matern,Cristina Amat Di San Filippo,Marzia Pasquali,Susan A. Berry,Nicola Longo	2006	72
16	Pitfalls in Newborn Screening The Journal of Pediatrics ·Eric Crombez,Richard Koch,Stephen D. Cederbaum	2005	2
17	Hyperargininemia due to liver arginase deficiency Molecular Genetics and Metabolism ·Eric Crombez,Stephen D. Cederbaum	2004	107
18	Isolation and Characterization of the Human and Mouse Homologues (SUPT4H andSupt4h) of the Yeast SPT4 Gene Genomics ·Pei-Wen Chiang,Su-Qing Wang,Benedita Maria do Socorro Campo de Sousa,Woo‐Joo Song,Eric Crombez,Jacqueline A. Watson,Sérgio Nunes de Jesus,Jason Greenfield,Saravanan Ramamoorthy,Leon Rakoš,Clare Blackburn,GSpecchia,David M. Kurnit	1996	18
19	Identification and Analysis of the Human and Murine Putative Chromatin Structure Regulator SUPT6H andSupt6h Genomics ·Pei-Wen Chiang,Su-Qing Wang,Benedita Maria do Socorro Campo de Sousa,Woo‐Joo Song,Saravanan Ramamoorthy,Rickardo Ramos,Riana Sari,Margaret L. Van Keuren,Eric Crombez,Xiao Chenfe,Thomas W. Glover,Diane E. Miller,GSpecchia,Clare Blackburn,M. Sikola,Zhiguang Sun,Jan‐Fang Cheng,Julie R. Korenberg,David M. Kurnit	1996	24
20	Expressed Sequence Tags from the Long Arm of Human Chromosome 21 Genomics ·Pei-Wen Chiang,Grzegorz Dzida,Kachan,Jan‐Fang Cheng,Woo‐Joo Song,Eric Crombez,Chih-Shan Lee,David M. Kurnit	1995	6

About Eric Crombez

Eric Crombez is a scholar working on Clinical Biochemistry, Physiology and Aging, having authored 30 papers that have together received 856 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (13 papers), Metabolism and Genetic Disorders (9 papers), Carbohydrate Chemistry and Synthesis (6 papers), Biochemical and Molecular Research (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Mitochondrial Function and Pathology (3 papers), Cellular transport and secretion (3 papers) and Transgenic Plants and Applications (3 papers). The work is most often cited by research in Clinical Biochemistry (415 citations), Physiology (448 citations) and Biochemistry (90 citations). Eric Crombez has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Stephen D. Cederbaum, Ari Zimran, Nicola Longo, Deborah Elstein, Barbara K. Burton, Heidi Christ‐Schmidt, Jon A. Wolff, Alex Dorenbaum, Judith D. Bebchuk and Paul Harmatz. Their work appears in journals such as Molecular Genetics and Metabolism, American Journal of Hematology, The Journal of Pediatrics, Genomics and Journal of Inherited Metabolic Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact